Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 1
2(50.0%)
4Total
Phase 4(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05212116Phase 1Withdrawn

A Study of SDI-118 in Participants in Remission From Depression

Role: collaborator

NCT02546310Phase 1Completed

Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects

Role: collaborator

NCT01140620Phase 4Completed

Effects of Ketamine and Risperidone on Cognition

Role: collaborator

NCT01101685Phase 4Completed

Neural Responses and Dysphoria: Modulation by a Pharmacological Probe

Role: collaborator

All 4 trials loaded